Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
Thomas Powles(St Bartholomew's Hospital), Srikala S. Sridhar(University Health Network), Yohann Loriot(Inserm), Joaquim Bellmunt(Beth Israel Deaconess Medical Center), Xinmeng Jasmine Mu(Pfizer (United States)), Keith A. Ching(Pfizer (United States)), Jie Pu(Pfizer (United States)), Cora N. Sternberg(Cornell University), Daniel P. Petrylak(Yale Cancer Center), Rosa Tambaro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Louis Marie Dourthe, Carlos Álvarez-Fernández(Instituto de Investigación Sanitaria del Principado de Asturias), Maureen J.B. Aarts(Maastricht University Medical Centre), Alessandra di Pietro(Pfizer (Italy)), Petros Grivas(Seattle Cancer Care Alliance), Craig B. Davis(Pfizer (United States))
Cited by 115
Abstract
Related Papers
No related papers found
Powered by citation graph analysis